# CPMV (Mosaic Immunoengineering, Inc.) - SEC EDGAR Financial Statements

> Mosaic Immunoengineering, Inc. reported $151 in total assets and a net loss of $688K through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CPMV
- Markdown: https://convexityos.com/fundamentals/CPMV.md
- SEC CIK: 0000836564
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:14 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000836564&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$602K | Operating profit |
| Net Income | FY 2025 | -$688K | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.10 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $151 | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $64K | $184K | $435K | $1.05M | $1.46M | -- | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | -- | $996K | $734K | $1.05M | $1.22M | $1.58M |
| Total Operating Expenses | $616K | $880K | $1.40M | $2.63M | $3.50M | $996K | $734K | $1.05M | $1.22M | $1.58M |
| **Operating Income** | -$616K | -$880K | -$1.40M | -$2.63M | -$3.50M | -$996K | -$734K | -$1.05M | -$1.22M | -- |
| **EBITDA** | -- | -- | -- | -- | -- | -$996K | -$734K | -$1.05M | -$1.22M | -- |
| Interest Expense | $10K | $7.0K | $0 | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$685K | -$920K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$797K | -$1.26M | -$43K | -$1.26M |
| Income Tax Expense | $2.4K | $2.4K | $2.4K | $2.4K | $2.4K | $1.6K | $1.6K | -$50K | $2.4K | $2.4K |
| **Net Income** | -$688K | -$922K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$798K | -$1.21M | -$45K | -$1.27M |
| Basic EPS | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| **Diluted EPS** | -$0.10 | -$0.13 | -$0.14 | -$0.33 | -$0.55 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Basic Shares Outstanding | 7.2M | 7.2M | 7.2M | 7.2M | 6.7M | 398.5M | 398.5M | 398.5M | 398.5M | 398.5M |
| Diluted Shares Outstanding | -- | 7.2M | 7.2M | 7.2M | 6.7M | 398.5M | 398.5M | 398.5M | 398.5M | 398.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $16K | $16K | $16K | $16K | $16K | $16K | $16K | $16K |
| Total Operating Expenses | $142K | $157K | $155K | $148K | $144K | $149K | $175K | $150K |
| **Operating Income** | -$142K | -$157K | -$155K | -$148K | -$144K | -$149K | -$175K | -$150K |
| Interest Expense | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $2.5K | $3.0K |
| Income Before Tax | -$163K | -$177K | -$175K | -$169K | -$165K | -$170K | -$181K | -$151K |
| Income Tax Expense | $2.4K | $0 | $0 | $0 | $0 | $2.4K | $0 | $2.4K |
| **Net Income** | -$166K | -$177K | -$175K | -$169K | -$165K | -$172K | -$181K | -$153K |
| Basic EPS | -$0.02 | -$0.02 | -$0.02 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| **Diluted EPS** | -$0.02 | -$0.02 | -$0.02 | -- | -$0.02 | -$0.02 | -$0.03 | -- |
| Basic Shares Outstanding | 7.2M | 7.2M | 7.2M | -- | 7.2M | 7.2M | 7.2M | -- |
| Diluted Shares Outstanding | 7.2M | 7.2M | 7.2M | -- | 7.2M | 7.2M | 7.2M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $3.6K | $115K | $156K | $221K | $226K | $353K | $500 | $787K | $2.30M | $980K |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | $0 | $750K | $0 | $2.20M |
| **Cash & Short-Term Investments** | $3.6K | $115K | $156K | $221K | $226K | $353K | $500 | $1.54M | $2.30M | $3.18M |
| **Total Current Assets** | $20K | $142K | $180K | $261K | $269K | $458K | $563 | $1.79M | $2.33M | $3.32M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | $326 | $814 | $1.3K | $1.9K |
| Long-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $135K | $253K | $444K |
| **Total Assets** | $20K | $142K | $180K | $261K | $269K | $458K | $563 | $1.92M | $2.58M | $3.76M |
| Accounts Payable | $133K | $135K | $118K | $133K | $114K | $86K | $0 | $8.9K | $45K | $14K |
| **Total Current Liabilities** | $6.03M | $5.54M | $4.73M | $3.92M | $2.33M | $880K | $1.0K | $228K | $85K | $57K |
| **Total Non-Current Liabilities** | $1.47M | $1.39M | $1.32M | $1.23M | $735K | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $7.50M | $6.93M | $6.05M | $5.15M | $3.07M | $880K | $1.0K | $228K | $85K | $57K |
| Common Stock | $72 | $72 | $72 | $72 | $72 | $8 | $0 | $4.4K | $4.4K | $4.4K |
| Retained Earnings | -$9.53M | -$8.84M | -$7.92M | -$6.91M | -$4.53M | -$843K | -$511 | -$61.13M | -$60.33M | -$59.12M |
| **Total Stockholders' Equity** | -$7.48M | -$6.79M | -$5.87M | -$4.88M | -$2.80M | -$423K | -$448 | $1.70M | $2.50M | $3.70M |
| Total Equity | -$7.48M | -$6.79M | -$5.87M | -$4.88M | -$2.80M | -$423K | -$448 | $1.70M | $2.50M | $3.70M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $151 | $26 | $72 | $3.6K | $32K | $54K | $86K | $115K |
| **Cash & Short-Term Investments** | $151 | $26 | $72 | $3.6K | $32K | $54K | $86K | $115K |
| **Total Current Assets** | $151 | $3.3K | $9.8K | $20K | $55K | $58K | $98K | $142K |
| **Total Non-Current Assets** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Assets** | $151 | $3.3K | $9.8K | $20K | $55K | $58K | $98K | $142K |
| Accounts Payable | $197K | $183K | $167K | $133K | $134K | $134K | $138K | $135K |
| **Total Current Liabilities** | $6.47M | $6.33M | $6.18M | $6.03M | $5.91M | $5.77M | $5.66M | $5.54M |
| **Total Non-Current Liabilities** | $1.52M | $1.50M | $1.48M | $1.47M | $1.45M | $1.43M | $1.41M | $1.39M |
| **Total Liabilities** | $7.99M | $7.83M | $7.66M | $7.50M | $7.36M | $7.20M | $7.07M | $6.93M |
| Common Stock | $72 | $72 | $72 | $72 | $72 | $72 | $72 | $72 |
| Retained Earnings | -$10.04M | -$9.88M | -$9.70M | -$9.53M | -$9.36M | -$9.19M | -$9.02M | -$8.84M |
| **Total Stockholders' Equity** | -$7.99M | -$7.83M | -$7.65M | -$7.48M | -$7.31M | -$7.14M | -$6.97M | -$6.79M |
| Total Equity | -$7.99M | -$7.83M | -$7.65M | -$7.48M | -$7.31M | -$7.14M | -$6.97M | -$6.79M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$688K | -$922K | -$1.01M | -$2.38M | -$3.68M | -$1.06M | -$798K | -$1.21M | -$45K | -$1.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | $488 | $489 | $763 | $826 | $1.3K |
| Stock-Based Compensation | $0 | $4.9K | $22K | $295K | $1.31M | -- | -- | -- | -- | $0 |
| **Operating Cash Flow** | -$111K | -$241K | -$497K | -$690K | -$679K | -$987K | -$761K | -$880K | -$1.31M | -$1.58M |
| Capital Expenditure | -- | -- | -- | -- | -- | -- | $0 | -$1.5K | -$2.7K | $0 |
| **Free Cash Flow** | -- | -- | -- | -- | -- | -- | -$761K | -$882K | -$1.31M | -$1.58M |
| Purchases of Investments | -- | -- | -- | -- | -- | -$250K | -$750K | -$2.70M | -$2.95M | -$2.45M |
| **Investing Cash Flow** | -- | $0 | $433K | $343K | $28K | $750K | -$573K | $2.20M | $1.13M | $58K |
| Common Stock Issued | -- | -- | -- | -- | $0 | -- | -- | -- | -- | -- |
| **Financing Cash Flow** | $0 | $200K | $0 | $342K | $525K | -- | -- | -- | -- | -- |
| **Net Change in Cash** | -$111K | -$41K | -$64K | -$5.5K | -$127K | -$237K | -$1.33M | $1.32M | -$180K | -$1.52M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$166K | -$177K | -$175K | -$169K | -$165K | -$172K | -$181K | -$153K |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Operating Cash Flow** | $125 | -$46 | -$3.5K | -$28K | -$22K | -$32K | -$29K | -$21K |
| **Investing Cash Flow** | -- | -- | -- | -- | -- | -- | -- | $0 |
| **Net Change in Cash** | $125 | -$46 | -$3.5K | -$28K | -$22K | -$32K | -$29K | $109K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -- | -- | -- | -- | -- | -- | -47.1% | -48.5% | -1.2% | -33.8% |
| Return on Assets (ROA) | -3459.6% | -651.1% | -561.6% | -911.2% | -1367.2% | -188370.9% | -41.5% | -46.9% | -1.2% | -33.1% |
| Current Ratio | 0.00x | 0.03x | 0.04x | 0.07x | 0.12x | 0.56x | 7.84x | 27.43x | 58.62x | 42.89x |
| Quick Ratio | 0.00x | 0.02x | 0.03x | 0.06x | 0.10x | 0.49x | 6.74x | 27.09x | 56.25x | 42.37x |
| 5Y Net Income / Share Growth | -- | -- | -- | -- | -- | -- | -- | -211.4% | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -455548.3% | -20968.4% | -6938.1% | -3459.6% | -1214.8% | -1201.3% | -833.3% | -651.1% |
| Current Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.03x |
| Quick Ratio | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
